Almost a virus – how AAV powers modern gene therapy
In this episode, the hosts sit down with Dr. Dan Mitchell of Matica Biotechnology to explore how viral vectors are engineered, analyzed, and manufactured for cell and gene therapy. The conversation spans CDMO workflows, AAV biology, and the critical role of qPCR and digital PCR in ensuring safety, quality, and performance.
Absolute Gene-ius · Dan Mitchell, Lisa Crawford, Jordan Ruggieri
Show Notes
Viruses are not always something to fear; they can also be tools to heal. This episode looks into this positive side of viral biology.
Dr. Dan Mitchell, Senior Director of Analytical Development and Quality Control at Matica Biotechnology, joins the show to unpack the science and strategy behind viral vector manufacturing in a CDMO environment. He explains what CDMOs do, how they support cell and gene therapy programs at every stage, and why AAV has become such a powerful delivery vehicle. Dan dives deep into analytical development, describing how technologies like qPCR and digital PCR are used to quantify viral genomes, assess empty-to-full ratios, detect residual host cell DNA, and identify rare recombination events. He also discusses how sequencing, infectivity assays, and orthogonal analytics come together to ensure safety, potency, and regulatory readiness.
In Lisa’s Career Corner, Dan traces his path from marine biology curiosity to high-containment virology labs, pressure suits included. He encourages young scientists to get into the lab early, embrace failure as learning, stay curious and find the patience it takes to succeed in science.
Visit the Absolute Gene-ius page to learn more about the guests, the hosts, and the science we explore. Discover the Applied Biosystems QuantStudio Digital and Real-Time PCR Systems powering real-world research across neuroscience, oncology, agriculture, and more.